Showing 181 - 200 results of 1,132 for search '"immunosuppression"', query time: 0.06s Refine Results
  1. 181
  2. 182
  3. 183

    A Potential Concept In The Management of Tumors With Modulation of Prostaglandin, Nitric Oxide and Antioxidants by Noori S. Al-Waili

    Published 2007-01-01
    “…Tumors are associated with immunosuppression and anemia. We have hypothesized that the over-production of PGs is responsible for immunosuppression and anemia in conditions associated with increased production of PG such as tumor, and that PG inhibitors might help reversing immunosuppression and anemia, and play a role in eradication and prevention of tumors. …”
    Get full text
    Article
  4. 184

    Early Gastric Post-Transplant Lymphoproliferative Disorder and H pylori Detection after Kidney Transplantation: A Case Report and Review of the Literature by CL Nash, LM Price, DA Stewart, F Sepandj, S Yilmaz, A Barama

    Published 2000-01-01
    “…In the era of cyclosporine immunosuppression, the incidence of PTLD affecting the gastrointestinal tract may be increasing in comparison with the incidence seen with the use of older immunosuppression regimens. …”
    Get full text
    Article
  5. 185
  6. 186

    A Decade of Experience Using mTor Inhibitors in Liver Transplantation by Jeffrey Campsen, Michael A. Zimmerman, Susan Mandell, Maria Kaplan, Igal Kam

    Published 2011-01-01
    “…Patients that received SRL as primary immunosuppression had 50% less rejection compared to controls.…”
    Get full text
    Article
  7. 187

    Anaesthesia affects immune function and impact on long-term cancer prognosis: A review by Kisdyanti Yuniar Melissa, Suandika Made, Rahmawati Arni Nur

    Published 2025-01-01
    “…Anti-tumour immunity is compromised by local and systemic immunosuppression, which may ultimately contribute to tumor survival and the long-term prognosis of cancer patients. …”
    Get full text
    Article
  8. 188

    Effect of innate and induced immunity on infectious bursal disease pathogenesis by A. N. Semina

    Published 2023-09-01
    “…In case of IBD, the immunosuppression is both direct consequence of specific target-cell infection and indirect consequence of the interactions occurring in the bird’s immune network. …”
    Get full text
    Article
  9. 189

    Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients by David Arroyo, Sindhu Chandran, Parsia A. Vagefi, David Wojciechowski

    Published 2014-01-01
    “…BK virus (BKV) infection is a common complication following kidney transplantation. Immunosuppression reduction is the cornerstone of treatment while adjuvant drugs have been tried in small uncontrolled studies. …”
    Get full text
    Article
  10. 190

    Insights into the Roles of B Cells in Patients with Sepsis by Xijie Dong, Hao Tu, Shuang Qin, Xiangjun Bai, Fan Yang, Zhanfei Li

    Published 2023-01-01
    “…Dysfunction of B cells, along with aggravated immunosuppression, are closely related to poor prognosis. …”
    Get full text
    Article
  11. 191

    Homeostatic T Cell Proliferation after Islet Transplantation by Paolo Monti, Lorenzo Piemonti

    Published 2013-01-01
    “…Pancreatic islet transplantation in patients with type 1 diabetes mellitus is performed under immunosuppression to avoid alloreactive T cell responses and to control the reactivation of autoreactive memory T cells. …”
    Get full text
    Article
  12. 192

    Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1 by Yury Rubtsov, Кirill Goryunov, Аndrey Romanov, Yulia Suzdaltseva, George Sharonov, Vsevolod Tkachuk

    Published 2017-01-01
    “…ICAM-1 is involved in the control of T cell activation leading to immunosuppression or modest stimulation depending on the T cell status. …”
    Get full text
    Article
  13. 193

    CNS Vasculitis Associated with Waldenström Macroglobulinemia by Tanawan Riangwiwat, Chris Y. Wu, Alberto S. Santos-Ocampo, Randal J. Liu, Aaron M. McMurtray, Beau K. Nakamoto

    Published 2016-01-01
    “…To our knowledge, CNS vasculitis in a WM patient, in the absence of cryoglobulins, has not been reported. Immunosuppression is the preferred treatment.…”
    Get full text
    Article
  14. 194

    Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19 by Aliede E. in ‘t Veld, Manon A. A. Jansen, Luuk C. A. Ciere, Matthijs Moerland

    Published 2021-01-01
    “…We argue that the clinical effect of prophylactic or therapeutic HCQ treatment in COVID-19 depends on the balance between inhibition of viral replication, immunosuppression, and off-target side effects, and that the outcome is probably dependent on disease stage and disease severity. …”
    Get full text
    Article
  15. 195

    Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody by Bruce E. Gelb, J. Rodrigo Diaz-Siso, Natalie M. Plana, Adam Jacoby, William J. Rifkin, Kimberly S. Khouri, Daniel J. Ceradini, Eduardo D. Rodriguez

    Published 2018-01-01
    “…To our knowledge, this is the first report of targeted B cell agents used for induction immunosuppression in skin-containing vascularized composite tissue allotransplantation. …”
    Get full text
    Article
  16. 196

    Glioblastoma Multiforme Stem Cells by Irena Dimov, Deasanka Tasic-Dimov, Irena Conic, Vladisav Stefanovic

    Published 2011-01-01
    “…Therefore, a comprehensive understanding of the mechanisms underlying the GBM-induced immunosuppression is indispensable. This review presents a summary of the present knowledge both on GBMSCs and the GBM, and/or GBMSC-related mechanisms of developing both local and systemic immunosuppression, of which an understanding may lead to the development of the novel and effective therapeutic strategies.…”
    Get full text
    Article
  17. 197

    Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

    Published 2024-08-01
    “…The primary drivers of preexisting immunosuppression and inflammation are non-HIV infections and possibly alloantigen and drug exposures. …”
    Get full text
    Article
  18. 198
  19. 199

    The Need for Inducing Tolerance in Vascularized Composite Allotransplantation by Kadiyala V. Ravindra, Hong Xu, Larry D. Bozulic, David D. Song, Suzanne T. Ildstad

    Published 2012-01-01
    “…In order to optimize VCA outcomes, translational studies are needed to develop less toxic immunosuppression and possibly achieve donor-specific tolerance. …”
    Get full text
    Article
  20. 200